On Monday, CERo Therapeutics Holdings Inc (NASDAQ: CERO) opened lower -11.99% from the last session, before settling in for the closing price of $0.45. Price fluctuations for CERO have ranged from $0.40 to $98.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 73.05% at the time writing. With a float of $5.44 million, this company’s outstanding shares have now reached $7.72 million.
In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
CERo Therapeutics Holdings Inc (CERO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CERo Therapeutics Holdings Inc is 29.58%, while institutional ownership is 9.08%. The most recent insider transaction that took place on Dec 13 ’24, was worth 179,934. In this transaction 10% Owner of this company sold 2,998,908 shares at a rate of $0.06, taking the stock ownership to the 13,005,169 shares. Before that another transaction happened on Dec 12 ’24, when Company’s 10% Owner sold 1,614,541 for $0.07, making the entire transaction worth $113,018. This insider now owns 16,004,077 shares in total.
CERo Therapeutics Holdings Inc (CERO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 73.05% per share during the next fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Check out the current performance indicators for CERo Therapeutics Holdings Inc (CERO). In the past quarter, the stock posted a quick ratio of 0.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -24.94, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -1.42 in one year’s time.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
CERo Therapeutics Holdings Inc (NASDAQ: CERO) saw its 5-day average volume 0.93 million, a negative change from its year-to-date volume of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 19.87%. Additionally, its Average True Range was 0.07.
During the past 100 days, CERo Therapeutics Holdings Inc’s (CERO) raw stochastic average was set at 0.18%, which indicates a significant decrease from 2.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.03% in the past 14 days, which was lower than the 135.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6635, while its 200-day Moving Average is $6.0134.
